BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Spartalis M, Iliopoulos DC, Spartalis E, Athanasiou A, Paschou SA, Voudris V, Siasos G. Is the clinical benefit of implantable cardioverter-defibrillators in heart failure patients declining? Journal of Cardiology 2020;75:583-4. [DOI: 10.1016/j.jjcc.2020.02.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Spartalis M, Nakajima K, Zweiker D, Spartalis E, Iliopoulos DC, Siasos G. Contemporary ICD Use in Patients with Heart Failure. Cardiol Ther 2021. [PMID: 34129228 DOI: 10.1007/s40119-021-00225-7] [Reference Citation Analysis]
2 Engstrom N, Dobson GP, Ng K, Letson HL. Primary Prevention Implantable Cardiac Defibrillators: A Townsville District Perspective. Front Cardiovasc Med 2020;7:577248. [PMID: 33195463 DOI: 10.3389/fcvm.2020.577248] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hata R, Kato T, Yaku H, Morimoto T, Kawase Y, Yamamoto E, Inuzuka Y, Tamaki Y, Ozasa N, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Morinaga T, Furukawa Y, Kadota K, Sato Y, Kimura T. Implantable Cardioverter Defibrillator Therapy in Patients with Acute Decompensated Heart Failure with Reduced Ejection Fraction: An Observation from the KCHF Registry. J Cardiol 2021;77:292-9. [PMID: 33191081 DOI: 10.1016/j.jjcc.2020.10.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]